PBS exit sparks access concerns

By Megan Brodie 5 months ago | In Patients, Products, Reimbursement
  • 5 months ago

11 May 2026 A decision by AstraZeneca to remove an older PBS-listed cancer product from…

This is subscriber-only content. Please login to continue reading.